Aug 24, 2011 by MedCity NewsCardinal Health Sees Opportunity (but Faces Challenges) in Specialty DrugsIs Cardinal up for the challenge?
Aug 24, 2011 by MedCity NewsGrowth Is the Deity Medtronic CEO Omar Ishrak Will WorshipCEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company.
Aug 13, 2011 by MedCity NewsInvestors Blocking Pfizer's Bid Say Icagen's Value Could Be $165 MillionPfizer is offering a third of that figure for the pharma.
Aug 10, 2011 by MedCity NewsAthersys More Threatened Than Most by Falling Share PriceRecent market movements have been brutal for small biotech Athersys.
Aug 6, 2011 by MedCity NewsMedtronic Jobs: Firm Will Double Chinese Workforce in 4 YearsThe company puts its focus on emerging markets.
Aug 4, 2011 by MedCity NewsMedtronic Infuse Device Will Be Reviewed by Yale ResearchersMedtronic works with Yale on a first-of-its-kind independent review.
Aug 4, 2011 by MedCity NewsSkin in the Game: How Acne Skin Care Fits GSK's Drug Portfolio StrategyGSK thinks long-term with this acne skin care product.
Jul 21, 2011 by MedCity NewsNew Hypertension Treatment from St. Jude Medical?St. Jude management is keeping mum.
Jul 16, 2011 by MedCity NewsMedtronic Invests in California Eye Lens Implant CompanyThe new device aims to mimic a natural lens.
Jul 15, 2011 by MedCity NewsSt. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in EuropeSt. Jude has an inventive new heart disease treatment.
Jul 13, 2011 by MedCity NewsFDA OKs Study Design on Medtronic Product That Firm Is Bullish OnGood news for Medtronic.
Jul 12, 2011 by MedCity NewsFDA Allows Expansion of St. Jude Study to Treat Severe DepressionSt. Jude moves forward with treatment for depression.
Jul 6, 2011 by MedCity NewsInfuse Furor May Force Medtronic Spine Business Sale. Who Would Buy?Jettisoning the spinal business may not be easy.
Jun 27, 2011 by MedCity NewsCardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other)Cardinal doesn't want to play, actually.
Jun 27, 2011 by MedCity NewsSt. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.?Was the trial as successful as St. Jude Medical hoped?
Jun 24, 2011 by MedCity NewsData on St. Jude Migraine Treatment "Impressive"An effective migraine treatment would be very valuable for St. Jude.
Jun 21, 2011 by MedCity NewsGSK HIV Drug Pipeline Sees Boost as Partner Concert Steers to Clinical TrialsGSK and Concert have a possible new treatment for HIV.
Jun 14, 2011 by MedCity NewsGSK Epilepsy Drug Approved by FDABut it must be classified as a controlled substance.
Jun 8, 2011 by MedCity NewsLorillard Hires FDA Official to Tackle Tobacco RegulationThe hire of Wilcox comes as menthol cigarettes are expected to come under stricter FDA scrutiny.
